The text analyzes ethical tensions associated with the development of neurotechnology and brain-computer interfaces (BCI). The author considers the dilemma between efficiency and fair access to cognitive enhancement technologies, pointing to the risk of perpetuating social privileges. A key point is the distinction between negative liberty (protection from interference) and positive liberty (access to therapy). In the face of these challenges, a deliberative governance approach is proposed, based on multi-stakeholder dialogue and Habermasian principles. The article also draws attention to the phenomenon of epistemic injustice, where the technical reading of biomarkers may dominate the patient's subjective experience, leading to their marginalization in the therapeutic process.
Fundacja Dobre Państwo
Posted on • Originally published at dobrepanstwo.org
Top comments (0)